IRF4 and rectum adenocarcinoma: The IRF4 expression levels were lower in Bladder urothelial carcinoma (BLCA), Breast invasive carcinoma (BRCA), Colon adenocarcinoma (COAD), Kidney chromophobe (KICH), Liver hepatocellular carcinoma (LIHC) and Rectum adenocarcinoma (READ).